UFP Tech

Q2 FY2026 EarningsQ2 FY26 results significantly beat consensus across all key metrics: revenue was $174.0M vs. $159.4M expected, and adjusted EPS reached $2.92 vs. the $2.56 mean estimate. The MedTech segment fueled the performance with top-5 customers growing 14.7% and the broader MedTech business surging 19.7%. Gross margin expanded to 29.3%, exceeding expectations of 28.7%, despite temporary mix and margin pressure from ongoing capacity expansions in the Dominican Republic.